RayzeBio, Inc. (RYZB) Misses Q3 EPS by 57c
RayzeBio, Inc. (NASDAQ: RYZB) reported Q3 EPS of ($1.26), $0.57 worse than the analyst estimate of ($0.69).
For earnings history and earnings-related data on RayzeBio, Inc. (RYZB) click here.
RayzeBio, Inc. (NASDAQ: RYZB) reported Q3 EPS of ($1.26), $0.57 worse than the analyst estimate of ($0.69).
For earnings history and earnings-related data on RayzeBio, Inc. (RYZB) click here.